Skip to main content Skip to section navigation Skip to footer
Partnering Careers
IMV Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • DPX Delivery Platform
    • Overview
    • Scientific Materials
  • Pipeline
    • Overview
    • Maveropepimut-S
    • Expanded Access
  • News & Media
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contacts
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect
  • CCAA Proceedings
  • Partnering
  • Careers

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • IR Calendar
    • Presentations
    • Scientific Materials
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Information
    • Proxy Information
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • OTC Pink: IMVIQ
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contacts
  • FAQ
Oct 08, 2020 7:05am EDT

IMV Provides Updates On COVID-19 Vaccine Program

Sep 16, 2020 7:05am EDT

IMV CEO to Participate at the Vaccines Panel of the Sachs Associates 20th Annual Biotech in Europe Forum

Aug 26, 2020 7:05am EDT

IMV to Participate at Four Upcoming Investor Conferences

Aug 12, 2020 7:05am EDT

IMV Inc. Announces Second Quarter 2020 Financial Results

Aug 05, 2020 7:05am EDT

IMV Receives Funding From Canadian Governmental Agencies for COVID-19 Vaccine Phase 1 Clinical Study

Aug 03, 2020 7:05am EDT

IMV Inc. to Announce Second Quarter 2020 Results and Host a Conference Call and Webcast on August 12, 2020

Jul 29, 2020 7:05am EDT

IMV to Present at BTIG’s Virtual Biotechnology Conference

Jul 20, 2020 7:05am EDT

IMV Announces Appointment of Michael P. Bailey to Board of Directors

Jul 14, 2020 7:05am EDT

IMV Updates Rapid Progress on COVID-19 Vaccine Program

Jun 30, 2020 5:05pm EDT

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

  • Previous Pagearrow_back
  • Page 1…
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …Page 43
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Visit us on Twitter

    Twitter

  • Visit us on LinkedIn

    LinkedIn

  • Visit us on Youtube

    Youtube

© IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap Manage Cookie Preferences